In this issue:
Low-value PSA screening in older males
ADT + enzalutamide for mHSPC
Vaccine-based immunotherapy regimen for prostate cancer
Localised prostate cancer treated with daratumumab or edicotinib
Five-year survival of patients with late-stage prostate cancer
Erectile tissue-sparing radiation therapy for localised prostate cancer
Neoadjuvant 177Lu-PSMA radionuclide before radical prostatectomy
Best practice and research priorities in AS
Incidence and survival of CRPC patients with visceral metastases
Combination systemic therapies in mHSPC
Please login below to download this issue (PDF)